Vertex Pharmaceuticals | Home
WEBVertex is a biotechnology company that develops medicines for serious diseases, such as cystic fibrosis, sickle cell disease, beta thalassemia, and type 1 diabetes. Learn about its latest news, clinical trials, and career opportunities.
Vertex Pharmaceuticals - Wikipedia
WEBVertex Pharmaceuticals is an American biopharmaceutical company that develops drugs for serious diseases. Learn about its origins, acquisitions, medicines for cystic fibrosis, and other treatments in development.
Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance
WEBGet the latest stock price, news, quote and history of Vertex Pharmaceuticals, a biotechnology company that develops and sells therapies for cystic fibrosis and other diseases. See its...
Vertex Pharmaceuticals | Our Company
WEBVertex is a biopharmaceutical company that creates transformative medicines for people with serious diseases. Learn about its mission, values, culture, R&D, and recognition as a Fortune 100 Best Company and a leader in biopharma.
Vertex Pharmaceuticals | Home
WEBVertex is a biotechnology company that develops and produces transformative medicines for people with serious diseases. Learn about their scientific innovation, corporate responsibility and inclusive culture.
Press Release - Vertex Pharmaceuticals Newsroom
WEBJun 21, 2024 · Vertex presents positive results from a Phase 1/2 study of VX-880, a stem cell-derived islet cell therapy for type 1 diabetes. VX-880 shows islet cell engraftment, glucose-responsive insulin production, and elimination of …
Press Release - Vertex Pharmaceuticals Newsroom
WEBDec 8, 2023 · Vertex leads global development, manufacturing and commercialization of CASGEVY with support from CRISPR Therapeutics. In conjunction with the FDA approval of CASGEVY, Vertex will make a $200 million milestone payment to CRISPR, which will be capitalized and amortized to cost of sales.
Vertex Pharmaceuticals - LinkedIn
WEBAug 10, 2014 · Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and...
Newsroom | Vertex Pharmaceuticals Newsroom
WEBFind the latest news and updates from Vertex Pharmaceuticals, a biotechnology company focused on cystic fibrosis and other serious diseases. Learn about its R&D pipeline, financial results, leadership team, and media library.
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: …
WEB5 days ago · Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day. This move outpaced the S&P 500's daily gain of 0.13%. At the same time, the ...